エリスロポエチン刺激剤の世界市場、2024～2028年

エリスロポエチン刺激剤市場、2024～2028年

エリスロポエチン刺激剤市場は2023～2028年に45億540万米ドル、予測期間中のCAGRは8.5%で成長すると予測されます。当レポートでは、エリスロポエチン刺激剤市場の全体的な分析、市場規模・予測、動向、成長促進要因、課題、約25のベンダーを網羅したベンダー分析などを掲載しています。

現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。同市場は、多数のCKD患者の存在、HIV感染症や末期腎障害における用途の増加、手術中の血栓症リスク、純赤血球無形成症などが牽引しています。

本調査では、新興経済諸国におけるCKD透析センターの増加が、今後数年間のエリスロポエチン刺激剤市場成長を牽引する主要因の1つであるとしています。また、ベンダー間の戦略的提携の増加や、改良型エリスロポエチン製剤を開発するための研究開発投資の増加も、市場の大きな需要につながると考えられます。

目次

第1章 エグゼクティブサマリー

• 市場概要

第2章 市場情勢

• 市場エコシステム
• 市場の特徴
• バリューチェーン分析

第3章 市場規模の評価

• 市場の定義
• 市場セグメント分析
• 市場規模 2023年
• 市場の展望 2023～2028年

第4章 市場規模実績

• エリスロポエチン刺激剤の世界市場 2018～2022年
• タイプ別セグメント分析 2018～2022年
• 地域別セグメント分析 2018～2022年
• 国別セグメント分析 2018～2022年

第5章 ファイブフォース分析

• ファイブフォースの要約
• 買い手の交渉力
• 供給企業の交渉力
• 新規参入業者の脅威
• 代替品の脅威
• 競争の脅威
• 市況

第6章 市場セグメンテーション：タイプ別

• 市場セグメンテーション
• 比較：タイプ別
• エポエチンアルファ：市場規模と予測 2023～2028年
• エポエチンベータ：市場規模と予測 2023～2028年
• ダルベポエチンアルファ：市場規模と予測 2023～2028年
• その他：市場規模と予測 2023～2028年
• タイプ別の市場機会

第7章 顧客情勢

• 顧客情勢概要

第8章 地域別情勢

• 地域別セグメンテーション
• 比較：地域別
• 北米：市場規模と予測 2023～2028年
• 欧州：市場規模と予測 2023～2028年
• アジア：市場規模と予測 2023～2028年
• その他：市場規模と予測 2023～2028年
• 米国：市場規模と予測 2023～2028年
• ドイツ：市場規模と予測 2023～2028年
• 英国：市場規模と予測 2023～2028年
• カナダ：市場規模と予測 2023～2028年
• 中国：市場規模と予測 2023～2028年
• 地域情勢別の市場機会

第9章 促進要因・課題・機会・抑制要因

• 市場促進要因
• 市場課題
• 促進要因と課題の影響
• 市場の機会・抑制要因

第10章 競合情勢

• 概要
• 競合情勢
• 混乱の状況
• 業界のリスク

第11章 競合分析

• 企業プロファイル
• 企業の市場ポジショニング
• Akebia Therapeutics
• Amgen Inc.
• Biocon Ltd.
• Biosidus SA
• F. Hoffmann La Roche Ltd.
• Johnson and Johnson Services Inc.
• Nanogen Pharmaceutical Biotechnology
• Novartis AG
• Pfizer Inc.
• Thermo Fisher Scientific Inc.

第12章 付録

Exhibits:

• Exhibits1: Executive Summary - Chart on Market Overview
• Exhibits2: Executive Summary - Data Table on Market Overview
• Exhibits3: Executive Summary - Chart on Global Market Characteristics
• Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
• Exhibits5: Executive Summary - Chart on Market Segmentation by Type
• Exhibits6: Executive Summary - Chart on Incremental Growth
• Exhibits7: Executive Summary - Data Table on Incremental Growth
• Exhibits8: Executive Summary - Chart on Company Market Positioning
• Exhibits9: Parent Market
• Exhibits10: Data Table on - Parent Market
• Exhibits11: Market characteristics analysis
• Exhibits12: Value Chain Analysis
• Exhibits13: Offerings of companies included in the market definition
• Exhibits14: Market segments
• Exhibits15: Chart on Global - Market size and forecast 2023-2028 ($ million)
• Exhibits16: Data Table on Global - Market size and forecast 2023-2028 ($ million)
• Exhibits17: Chart on Global Market: Year-over-year growth 2023-2028 (%)
• Exhibits18: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
• Exhibits19: Historic Market Size - Data Table on Global Erythropoietin Stimulating Agents Market 2018 - 2022 ($ million)
• Exhibits20: Historic Market Size - Type Segment 2018 - 2022 ($ million)
• Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
• Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
• Exhibits23: Five forces analysis - Comparison between 2023 and 2028
• Exhibits24: Bargaining power of buyers - Impact of key factors 2023 and 2028
• Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
• Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028
• Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028
• Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028
• Exhibits29: Chart on Market condition - Five forces 2023 and 2028
• Exhibits30: Chart on Type - Market share 2023-2028 (%)
• Exhibits31: Data Table on Type - Market share 2023-2028 (%)
• Exhibits32: Chart on Comparison by Type
• Exhibits33: Data Table on Comparison by Type
• Exhibits34: Chart on Epoetin alfa - Market size and forecast 2023-2028 ($ million)
• Exhibits35: Data Table on Epoetin alfa - Market size and forecast 2023-2028 ($ million)
• Exhibits36: Chart on Epoetin alfa - Year-over-year growth 2023-2028 (%)
• Exhibits37: Data Table on Epoetin alfa - Year-over-year growth 2023-2028 (%)
• Exhibits38: Chart on Epoetin beta - Market size and forecast 2023-2028 ($ million)
• Exhibits39: Data Table on Epoetin beta - Market size and forecast 2023-2028 ($ million)
• Exhibits40: Chart on Epoetin beta - Year-over-year growth 2023-2028 (%)
• Exhibits41: Data Table on Epoetin beta - Year-over-year growth 2023-2028 (%)
• Exhibits42: Chart on Darbepoetin alfa - Market size and forecast 2023-2028 ($ million)
• Exhibits43: Data Table on Darbepoetin alfa - Market size and forecast 2023-2028 ($ million)
• Exhibits44: Chart on Darbepoetin alfa - Year-over-year growth 2023-2028 (%)
• Exhibits45: Data Table on Darbepoetin alfa - Year-over-year growth 2023-2028 (%)
• Exhibits46: Chart on Others - Market size and forecast 2023-2028 ($ million)
• Exhibits47: Data Table on Others - Market size and forecast 2023-2028 ($ million)
• Exhibits48: Chart on Others - Year-over-year growth 2023-2028 (%)
• Exhibits49: Data Table on Others - Year-over-year growth 2023-2028 (%)
• Exhibits50: Market opportunity by Type ($ million)
• Exhibits51: Data Table on Market opportunity by Type ($ million)
• Exhibits52: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• Exhibits53: Chart on Market share By Geographical Landscape 2023-2028 (%)
• Exhibits54: Data Table on Market share By Geographical Landscape 2023-2028 (%)
• Exhibits55: Chart on Geographic comparison
• Exhibits56: Data Table on Geographic comparison
• Exhibits57: Chart on North America - Market size and forecast 2023-2028 ($ million)
• Exhibits58: Data Table on North America - Market size and forecast 2023-2028 ($ million)
• Exhibits59: Chart on North America - Year-over-year growth 2023-2028 (%)
• Exhibits60: Data Table on North America - Year-over-year growth 2023-2028 (%)
• Exhibits61: Chart on Europe - Market size and forecast 2023-2028 ($ million)
• Exhibits62: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
• Exhibits63: Chart on Europe - Year-over-year growth 2023-2028 (%)
• Exhibits64: Data Table on Europe - Year-over-year growth 2023-2028 (%)
• Exhibits65: Chart on Asia - Market size and forecast 2023-2028 ($ million)
• Exhibits66: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
• Exhibits67: Chart on Asia - Year-over-year growth 2023-2028 (%)
• Exhibits68: Data Table on Asia - Year-over-year growth 2023-2028 (%)
• Exhibits69: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
• Exhibits70: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
• Exhibits71: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• Exhibits72: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• Exhibits73: Chart on US - Market size and forecast 2023-2028 ($ million)
• Exhibits74: Data Table on US - Market size and forecast 2023-2028 ($ million)
• Exhibits75: Chart on US - Year-over-year growth 2023-2028 (%)
• Exhibits76: Data Table on US - Year-over-year growth 2023-2028 (%)
• Exhibits77: Chart on Germany - Market size and forecast 2023-2028 ($ million)
• Exhibits78: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
• Exhibits79: Chart on Germany - Year-over-year growth 2023-2028 (%)
• Exhibits80: Data Table on Germany - Year-over-year growth 2023-2028 (%)
• Exhibits81: Chart on UK - Market size and forecast 2023-2028 ($ million)
• Exhibits82: Data Table on UK - Market size and forecast 2023-2028 ($ million)
• Exhibits83: Chart on UK - Year-over-year growth 2023-2028 (%)
• Exhibits84: Data Table on UK - Year-over-year growth 2023-2028 (%)
• Exhibits85: Chart on Canada - Market size and forecast 2023-2028 ($ million)
• Exhibits86: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
• Exhibits87: Chart on Canada - Year-over-year growth 2023-2028 (%)
• Exhibits88: Data Table on Canada - Year-over-year growth 2023-2028 (%)
• Exhibits89: Chart on China - Market size and forecast 2023-2028 ($ million)
• Exhibits90: Data Table on China - Market size and forecast 2023-2028 ($ million)
• Exhibits91: Chart on China - Year-over-year growth 2023-2028 (%)
• Exhibits92: Data Table on China - Year-over-year growth 2023-2028 (%)
• Exhibits93: Market opportunity By Geographical Landscape ($ million)
• Exhibits94: Data Tables on Market opportunity By Geographical Landscape ($ million)
• Exhibits95: Impact of drivers and challenges in 2023 and 2028
• Exhibits96: Overview on criticality of inputs and factors of differentiation
• Exhibits97: Overview on factors of disruption
• Exhibits98: Impact of key risks on business
• Exhibits99: Companies covered
• Exhibits100: Matrix on companies position and classification
• Exhibits101: Akebia Therapeutics - Overview
• Exhibits102: Akebia Therapeutics - Product / Service
• Exhibits103: Akebia Therapeutics - Key offerings
• Exhibits104: Amgen Inc. - Overview
• Exhibits105: Amgen Inc. - Product / Service
• Exhibits106: Amgen Inc. - Key news
• Exhibits107: Amgen Inc. - Key offerings
• Exhibits108: Biocon Ltd. - Overview
• Exhibits109: Biocon Ltd. - Business segments
• Exhibits110: Biocon Ltd. - Key offerings
• Exhibits111: Biocon Ltd. - Segment focus
• Exhibits112: Biosidus SA - Overview
• Exhibits113: Biosidus SA - Product / Service
• Exhibits114: Biosidus SA - Key offerings
• Exhibits115: F. Hoffmann La Roche Ltd. - Overview
• Exhibits116: F. Hoffmann La Roche Ltd. - Business segments
• Exhibits117: F. Hoffmann La Roche Ltd. - Key news
• Exhibits118: F. Hoffmann La Roche Ltd. - Key offerings
• Exhibits119: F. Hoffmann La Roche Ltd. - Segment focus
• Exhibits120: Johnson and Johnson Services Inc. - Overview
• Exhibits121: Johnson and Johnson Services Inc. - Business segments
• Exhibits122: Johnson and Johnson Services Inc. - Key news
• Exhibits123: Johnson and Johnson Services Inc. - Key offerings
• Exhibits124: Johnson and Johnson Services Inc. - Segment focus
• Exhibits125: Nanogen Pharmaceutical Biotechnology - Overview
• Exhibits126: Nanogen Pharmaceutical Biotechnology - Product / Service
• Exhibits127: Nanogen Pharmaceutical Biotechnology - Key offerings
• Exhibits128: Novartis AG - Overview
• Exhibits129: Novartis AG - Business segments
• Exhibits130: Novartis AG - Key news
• Exhibits131: Novartis AG - Key offerings
• Exhibits132: Novartis AG - Segment focus
• Exhibits133: Pfizer Inc. - Overview
• Exhibits134: Pfizer Inc. - Product / Service
• Exhibits135: Pfizer Inc. - Key news
• Exhibits136: Pfizer Inc. - Key offerings
• Exhibits137: Thermo Fisher Scientific Inc. - Overview
• Exhibits138: Thermo Fisher Scientific Inc. - Business segments
• Exhibits139: Thermo Fisher Scientific Inc. - Key news
• Exhibits140: Thermo Fisher Scientific Inc. - Key offerings
• Exhibits141: Thermo Fisher Scientific Inc. - Segment focus
• Exhibits142: Inclusions checklist
• Exhibits143: Exclusions checklist
• Exhibits144: Currency conversion rates for US$
• Exhibits145: Research methodology
• Exhibits146: Information sources
• Exhibits147: Data validation
• Exhibits148: Validation techniques employed for market sizing
• Exhibits149: Data synthesis
• Exhibits150: 360 degree market analysis
• Exhibits151: List of abbreviations

Erythropoietin Stimulating Agents Market 2024-2028

The erythropoietin stimulating agents market is forecasted to grow by USD 4505.4 mn during 2023-2028, accelerating at a CAGR of 8.5% during the forecast period. The report on the erythropoietin stimulating agents market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by presence of large pool of ckd patients, rising applications in hiv infections and end-stage renal disorder, and risks of thrombosis, during surgeries, and pure red cell aplasia.

Technavio's erythropoietin stimulating agents market is segmented as below:

By Type

• Epoetin alfa
• Epoetin beta
• Darbepoetin alfa
• Others

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the growing number of ckd dialysis centers in developing economies as one of the prime reasons driving the erythropoietin stimulating agents market growth during the next few years. Also, increasing instances of strategic collaborations among vendors and increasing investments in research and development for developing new and improved erythropoietin products will lead to sizable demand in the market.

The report on the erythropoietin stimulating agents market covers the following areas:

• Erythropoietin Stimulating Agents Market sizing
• Erythropoietin Stimulating Agents Market forecast
• Erythropoietin Stimulating Agents Market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading erythropoietin stimulating agents market vendors that include 3SBio Inc., Akebia Therapeutics, Amgen Inc., Biocon Ltd., Biosidus SA, Dr Reddys Laboratories Ltd., F. Hoffmann La Roche Ltd., Johnson and Johnson Services Inc., Nanogen Pharmaceutical Biotechnology, NephroPlus, Novartis AG, Pfizer Inc., Reliance Industries Ltd., Renal Project, Thermo Fisher Scientific Inc., and Zydus Lifesciences Ltd.. Also, the erythropoietin stimulating agents market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market By Geographical Landscape
  • Executive Summary - Chart on Market Segmentation by Type
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
  • Parent Market
  • Data Table on - Parent Market
• 2.2 Market characteristics
  • Market characteristics analysis
• 2.3 Value chain analysis
  • Value Chain Analysis

3 Market Sizing

• 3.1 Market definition
  • Offerings of companies included in the market definition
• 3.2 Market segment analysis
  • Market segments
• 3.3 Market size 2023
• 3.4 Market outlook: Forecast for 2023-2028
  • Chart on Global - Market size and forecast 2023-2028 ($ million)
  • Data Table on Global - Market size and forecast 2023-2028 ($ million)
  • Chart on Global Market: Year-over-year growth 2023-2028 (%)
  • Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

• 4.1 Global Erythropoietin Stimulating Agents Market 2018 - 2022
  • Historic Market Size - Data Table on Global Erythropoietin Stimulating Agents Market 2018 - 2022 ($ million)
• 4.2 Type segment analysis 2018 - 2022
  • Historic Market Size - Type Segment 2018 - 2022 ($ million)
• 4.3 Geography segment analysis 2018 - 2022
  • Historic Market Size - Geography Segment 2018 - 2022 ($ million)
• 4.4 Country segment analysis 2018 - 2022
  • Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis

• 5.1 Five forces summary
  • Five forces analysis - Comparison between 2023 and 2028
• 5.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2023 and 2028
• 5.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2023 and 2028
• 5.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2023 and 2028
• 5.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2023 and 2028
• 5.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2023 and 2028
• 5.7 Market condition
  • Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Type

• 6.1 Market segments
  • Chart on Type - Market share 2023-2028 (%)
  • Data Table on Type - Market share 2023-2028 (%)
• 6.2 Comparison by Type
  • Chart on Comparison by Type
  • Data Table on Comparison by Type
• 6.3 Epoetin alfa - Market size and forecast 2023-2028
  • Chart on Epoetin alfa - Market size and forecast 2023-2028 ($ million)
  • Data Table on Epoetin alfa - Market size and forecast 2023-2028 ($ million)
  • Chart on Epoetin alfa - Year-over-year growth 2023-2028 (%)
  • Data Table on Epoetin alfa - Year-over-year growth 2023-2028 (%)
• 6.4 Epoetin beta - Market size and forecast 2023-2028
  • Chart on Epoetin beta - Market size and forecast 2023-2028 ($ million)
  • Data Table on Epoetin beta - Market size and forecast 2023-2028 ($ million)
  • Chart on Epoetin beta - Year-over-year growth 2023-2028 (%)
  • Data Table on Epoetin beta - Year-over-year growth 2023-2028 (%)
• 6.5 Darbepoetin alfa - Market size and forecast 2023-2028
  • Chart on Darbepoetin alfa - Market size and forecast 2023-2028 ($ million)
  • Data Table on Darbepoetin alfa - Market size and forecast 2023-2028 ($ million)
  • Chart on Darbepoetin alfa - Year-over-year growth 2023-2028 (%)
  • Data Table on Darbepoetin alfa - Year-over-year growth 2023-2028 (%)
• 6.6 Others - Market size and forecast 2023-2028
  • Chart on Others - Market size and forecast 2023-2028 ($ million)
  • Data Table on Others - Market size and forecast 2023-2028 ($ million)
  • Chart on Others - Year-over-year growth 2023-2028 (%)
  • Data Table on Others - Year-over-year growth 2023-2028 (%)
• 6.7 Market opportunity by Type
  • Market opportunity by Type ($ million)
  • Data Table on Market opportunity by Type ($ million)

7 Customer Landscape

• 7.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

8 Geographic Landscape

• 8.1 Geographic segmentation
  • Chart on Market share By Geographical Landscape 2023-2028 (%)
  • Data Table on Market share By Geographical Landscape 2023-2028 (%)
• 8.2 Geographic comparison
  • Chart on Geographic comparison
  • Data Table on Geographic comparison
• 8.3 North America - Market size and forecast 2023-2028
  • Chart on North America - Market size and forecast 2023-2028 ($ million)
  • Data Table on North America - Market size and forecast 2023-2028 ($ million)
  • Chart on North America - Year-over-year growth 2023-2028 (%)
  • Data Table on North America - Year-over-year growth 2023-2028 (%)
• 8.4 Europe - Market size and forecast 2023-2028
  • Chart on Europe - Market size and forecast 2023-2028 ($ million)
  • Data Table on Europe - Market size and forecast 2023-2028 ($ million)
  • Chart on Europe - Year-over-year growth 2023-2028 (%)
  • Data Table on Europe - Year-over-year growth 2023-2028 (%)
• 8.5 Asia - Market size and forecast 2023-2028
  • Chart on Asia - Market size and forecast 2023-2028 ($ million)
  • Data Table on Asia - Market size and forecast 2023-2028 ($ million)
  • Chart on Asia - Year-over-year growth 2023-2028 (%)
  • Data Table on Asia - Year-over-year growth 2023-2028 (%)
• 8.6 Rest of World (ROW) - Market size and forecast 2023-2028
  • Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
  • Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
  • Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• 8.7 US - Market size and forecast 2023-2028
  • Chart on US - Market size and forecast 2023-2028 ($ million)
  • Data Table on US - Market size and forecast 2023-2028 ($ million)
  • Chart on US - Year-over-year growth 2023-2028 (%)
  • Data Table on US - Year-over-year growth 2023-2028 (%)
• 8.8 Germany - Market size and forecast 2023-2028
  • Chart on Germany - Market size and forecast 2023-2028 ($ million)
  • Data Table on Germany - Market size and forecast 2023-2028 ($ million)
  • Chart on Germany - Year-over-year growth 2023-2028 (%)
  • Data Table on Germany - Year-over-year growth 2023-2028 (%)
• 8.9 UK - Market size and forecast 2023-2028
  • Chart on UK - Market size and forecast 2023-2028 ($ million)
  • Data Table on UK - Market size and forecast 2023-2028 ($ million)
  • Chart on UK - Year-over-year growth 2023-2028 (%)
  • Data Table on UK - Year-over-year growth 2023-2028 (%)
• 8.10 Canada - Market size and forecast 2023-2028
  • Chart on Canada - Market size and forecast 2023-2028 ($ million)
  • Data Table on Canada - Market size and forecast 2023-2028 ($ million)
  • Chart on Canada - Year-over-year growth 2023-2028 (%)
  • Data Table on Canada - Year-over-year growth 2023-2028 (%)
• 8.11 China - Market size and forecast 2023-2028
  • Chart on China - Market size and forecast 2023-2028 ($ million)
  • Data Table on China - Market size and forecast 2023-2028 ($ million)
  • Chart on China - Year-over-year growth 2023-2028 (%)
  • Data Table on China - Year-over-year growth 2023-2028 (%)
• 8.12 Market opportunity By Geographical Landscape
  • Market opportunity By Geographical Landscape ($ million)
  • Data Tables on Market opportunity By Geographical Landscape ($ million)

9 Drivers, Challenges, and Opportunity/Restraints

• 9.1 Market drivers
• 9.2 Market challenges
• 9.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2023 and 2028
• 9.4 Market opportunities/restraints

10 Competitive Landscape

• 10.1 Overview
• 10.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
• 10.3 Landscape disruption
  • Overview on factors of disruption
• 10.4 Industry risks
  • Impact of key risks on business

11 Competitive Analysis

• 11.1 Companies profiled
  • Companies covered
• 11.2 Market positioning of companies
  • Matrix on companies position and classification
• 11.3 Akebia Therapeutics
  • Akebia Therapeutics - Overview
  • Akebia Therapeutics - Product / Service
  • Akebia Therapeutics - Key offerings
• 11.4 Amgen Inc.
  • Amgen Inc. - Overview
  • Amgen Inc. - Product / Service
  • Amgen Inc. - Key news
  • Amgen Inc. - Key offerings
• 11.5 Biocon Ltd.
  • Biocon Ltd. - Overview
  • Biocon Ltd. - Business segments
  • Biocon Ltd. - Key offerings
  • Biocon Ltd. - Segment focus
• 11.6 Biosidus SA
  • Biosidus SA - Overview
  • Biosidus SA - Product / Service
  • Biosidus SA - Key offerings
• 11.7 F. Hoffmann La Roche Ltd.
  • F. Hoffmann La Roche Ltd. - Overview
  • F. Hoffmann La Roche Ltd. - Business segments
  • F. Hoffmann La Roche Ltd. - Key news
  • F. Hoffmann La Roche Ltd. - Key offerings
  • F. Hoffmann La Roche Ltd. - Segment focus
• 11.8 Johnson and Johnson Services Inc.
  • Johnson and Johnson Services Inc. - Overview
  • Johnson and Johnson Services Inc. - Business segments
  • Johnson and Johnson Services Inc. - Key news
  • Johnson and Johnson Services Inc. - Key offerings
  • Johnson and Johnson Services Inc. - Segment focus
• 11.9 Nanogen Pharmaceutical Biotechnology
  • Nanogen Pharmaceutical Biotechnology - Overview
  • Nanogen Pharmaceutical Biotechnology - Product / Service
  • Nanogen Pharmaceutical Biotechnology - Key offerings
• 11.10 Novartis AG
  • Novartis AG - Overview
  • Novartis AG - Business segments
  • Novartis AG - Key news
  • Novartis AG - Key offerings
  • Novartis AG - Segment focus
• 11.11 Pfizer Inc.
  • Pfizer Inc. - Overview
  • Pfizer Inc. - Product / Service
  • Pfizer Inc. - Key news
  • Pfizer Inc. - Key offerings
• 11.12 Thermo Fisher Scientific Inc.
  • Thermo Fisher Scientific Inc. - Overview
  • Thermo Fisher Scientific Inc. - Business segments
  • Thermo Fisher Scientific Inc. - Key news
  • Thermo Fisher Scientific Inc. - Key offerings
  • Thermo Fisher Scientific Inc. - Segment focus

12 Appendix

• 12.1 Scope of the report
• 12.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
• 12.3 Currency conversion rates for US$
  • Currency conversion rates for US$
• 12.4 Research methodology
  • Research methodology
• 12.5 Data procurement
  • Information sources
• 12.6 Data validation
  • Data validation
• 12.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
• 12.8 Data synthesis
  • Data synthesis
• 12.9 360 degree market analysis
  • 360 degree market analysis
• 12.10 List of abbreviations
  • List of abbreviations